Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Jan 09, 2021 2:08pm
202 Views
Post# 32261592

RE:RE:RE:RE:RE:RE:RE:Hold it Baby...

RE:RE:RE:RE:RE:RE:RE:Hold it Baby...I was worried about your recent out of character posts. I guess we are all TH fatigue add the stress  of pandemic to the equation sometimes it's just too much but hopefully 2021 and beyond will be the our turn to get rewarded with a decent appreciation of the SP forget $3 US and welcome back double digit....
Wino115 wrote:

Given the bashing we've all suffered in THTX for being overly optimistic, we have to take the little victories when we have one.  I enjoyed a nice Italian wine but it wasn't a blockbuster.    Please, everyone, save your absolute best bottle (or go by one in anticipation) for the day we hit a new all time high. Who knows when, but if we ever get there, we all deserve a toast together with something memorable.  Happy to provide recommendations but I sense most of you north of the border know a thing or two about good bottles from France and we have our west coast grand crus.

 

Lee430 wrote: Geez discovered after the bell today I had a death grip on my poor little mouse and was sweating after watching Thera struggle to close north of $3.00 today, my wife and I are celebrating tonight with a bottle of wine toasting Thera.


quote=Wino115]Oh yeah...I think we did it.  Thank you who ever trumped the Cheeto lovers! Yeeessss.....Enjoy your weekend with a smile and good glass of wine!
 

 

Wino115 wrote: Are you kidding me!  I bet a Cheeto lover told his desk to sell 1 share.  I demand a recount, it was taken from me!

Wino115 wrote: Hold you mothertrucker!  Someone click that buy at 3:59. We deserve a happy weekend for once.

Wino115 wrote:

We broke $3, I would love to see it put the $2 handle in our rear view mirror for good!  Please Hold Baby!

 

Wino115 wrote: I would love to see it hold a US$3 handle today for once.  It's been 2 years of not being able to hold breakouts. I have been consistent in saying they need to have true value-enhancing developments that should lead to concrete and incontrovertible market cap support.  We're seeing a bit of it today and beginning to walk down those paths.  The biggest supports are still to come. But if we can eliminate the "downside" that it's worth $2 something and slowly narrow the future value focus into view at higher levels, we may be on that path of gaining some share price momentum back in to it which all the portfolio managers younger than 50 want to see before they buy.  Let's hold that $3 level today!!
 

 

 


 

 

 




[/quote]

<< Previous
Bullboard Posts
Next >>